Actigall ®(ursodiol, USP) capsules |
PDF |
ACTONEL® (risedronate sodium) tablets |
PDF |
ACULAR LS® (ketorolac tromethamine ophthalmic solution) 0.4% |
PDF |
ACULAR® (ketorolac tromethamine ophthalmic solution) 0.5% |
PDF |
ACUVAIL® (ketorolac tromethamine ophthalmic solution) 0.45% |
PDF |
ACZONE® (dapsone) Gel 5% |
PDF |
ACZONE® (dapsone) Gel, 7.5% |
PDF |
AeroChamber Plus® Flow-Vu® Anti-Static Valved Holding Chamber |
PDF |
AeroChamber Plus® Flow-Vu® aVHC
Small Mask/Medium Mask |
PDF |
ALOCRIL® (nedocromil sodium ophthalmic solution) 2% |
PDF |
Alora (Estradiol Transdermal System, USP) |
PDF |
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% |
PDF |
ANDRODERM® (testosterone transdermal system), for topical use CIII |
PDF |
AquADEKs® Chewable Tablets (aqua-dex’) Multivitamin and Mineral Supplement |
PDF |
Armour® Thyroid (thyroid tablets, USP) |
PDF |
ASACOL® HD (mesalamine) delayed-release tablets, for oral use |
PDF |
ATELVIA® (risedronate sodium) delayed-release tablets |
PDF |
AVAGE® (tazarotene) Cream 0.1% |
PDF |
AVYCAZ (ceftazidime and avibactam) for injection, for intravenous use |
PDF |
AZELEX® (azelaic acid cream) 20% |
PDF |
BENTYL (dicyclomine hydrochloride) capsules, for oral use, BENTYL (dicyclomine hydrochloride) tablets, for oral use, BENTYL (dicyclomine hydrochloride) injection, for intramuscular use |
PDF |
BETAGAN® (levobunolol hydrochloride ophthalmic solution, USP) 0.5% |
PDF |
BLEPH®-10 (sulfacetamide sodium ophthalmic solution, USP) 10% |
PDF |
BLEPHAMIDE® (sulfacetamide sodium − prednisolone acetate ophthalmic suspension, USP) 10%/0.2% |
PDF |
BLEPHAMIDE® (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% |
PDF |
BOTOX® (onabotulinumtoxinA) |
PDF |
BOTOX® and BOTOX® Cosmetic Med Guide |
PDF |
BOTOX® Cosmetic (onabotulinumtoxinA) |
PDF |
Brevicon® (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg) |
PDF |
BYSTOLIC® (nebivolol) tablets, for oral use |
PDF |
BYVALSON (nebivolol and valsartan) tablets, for oral use |
PDF |
CANASA® (mesalamine) rectal suppository |
PDF |
CARAFATE® (sucralfate) Suspension |
PDF |
CARAFATE® (sucralfate) Tablets |
PDF |
Celexa® (citalopram hydrobromide) Tablets |
PDF |
COMBIGAN® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% |
PDF |
Condylox ® Gel (podofilox gel) |
PDF |
Condylox ® Topical Solution (podofilox solution) |
PDF |
Cordran® Tape Flurandrenolide Tape, USP |
PDF |
Crinone® (progesterone gel) |
PDF |
DALVANCE (dalbavancin) for injection, for intravenous use |
PDF |
DELZICOL (mesalamine) delayed-release capsules, for oral use |
PDF |
ELESTAT® (epinastine HCl ophthalmic solution) 0.05% |
PDF |
ENABLEX ® (darifenacin) extended-release tablets |
PDF |
ESTRACE® (estradiol vaginal cream, USP, 0.01%) |
PDF |
ESTROSTEP® Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets*) |
PDF |
femhrt® (norethindrone acetate/ethinyl estradiol tablets) |
PDF |
Femring® (estradiol acetate vaginal ring) |
PDF |
FETZIMA® (levomilnacipran) extended-release capsules, for oral use |
PDF |
Fiorinal® (Butalbital, Aspirin, and Caffeine Capsules, USP) |
PDF |
Fiorinal® with Codeine C-III (Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP) |
PDF |
FLUTTER® Mucus Clearance Device |
PDF |
FML FORTE® (fluorometholone ophthalmic suspension) 0.25% |
PDF |
FML® (fluorometholone ophthalmic ointment) 0.1% |
PDF |
FML® (fluorometholone ophthalmic suspension, USP) 0.1% |
PDF |
GELNIQUE (oxybutynin chloride) 10% Topical Gel |
PDF |
GENERESS Fe (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets) |
PDF |
INFeD (Iron Dextran Injection USP) |
PDF |
KADIAN® (morphine sulfate) extended-release capsules, for oral use, CII |
PDF |
KYBELLA (deoxycholic acid) injection, for subcutaneous use |
PDF |
LASTACAFT® (alcaftadine ophthalmic solution) 0.25% |
PDF |
LATISSE® (bimatoprost ophthalmic solution) 0.03% |
PDF |
Lexapro® (escitalopram oxalate) Tablets, Lexapro® (escitalopram oxalate) Oral Solution |
PDF |
LILETTA (levonorgestrel-releasing intrauterine system) |
PDF |
LILETTA® (levonorgestrel-releasing intrauterine system) SHI |
PDF |
LINZESS (linaclotide) capsules, for oral use |
PDF |
Lo Loestrin® Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) |
PDF |
Lo Minastrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) |
PDF |
LUMIGAN® 0.01% (bimatoprost ophthalmic solution) |
PDF |
MICROZIDE® (hydrochlorothiazide, USP) |
PDF |
Minastrin®24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) |
PDF |
MONUROL (fosfomycin tromethamine) sachet |
PDF |
NAMENDA (memantine HCl) tablets, for oral use, NAMENDA (memantine HCl) solution, for oral use |
PDF |
NAMENDA XR (memantine hydrochloride) extended release capsules, for oral use |
PDF |
NAMZARIC (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use |
PDF |
NEPHRO-VITE®RX (Vitamin B Complex and C Supplement) |
PDF |
NORCO® (Hydrocodone Bitartrate and Acetaminophen Tablets, USP) |
PDF |
Nor-QD® (Norethindrone 0.35 mg tablets USP) |
PDF |
OCUFLOX® (ofloxacin ophthalmic solution) 0.3% |
PDF |
OXYTROL (oxybutynin transdermal system) |
PDF |
OZURDEX® (dexamethasone intravitreal implant) 0.7 mg |
PDF |
POLYTRIM® (polymyxin B sulfate and trimethoprim ophthalmic solution, USP) |
PDF |
PRED FORTE® (prednisolone acetate ophthalmic suspension, USP) 1% |
PDF |
PRED MILD® (prednisolone acetate ophthalmic suspension, USP) 0.12% |
PDF |
PRED-G® (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% |
PDF |
PRED-G® (gentamicin and prednisolone acetate ophthalmic suspension, USP) 0.3%/1% |
PDF |
PreQue 10® (prenatal nutrition with CoQ10 and lycopene tablets) |
PDF |
PYLERA® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules |
PDF |
RAPAFLO® (silodosin) capsules |
PDF |
RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal use |
PDF |
REFRESH CONTACTS® Contact Lens Comfort Drops |
PDF |
RESTASIS MULTIDOSE™(cyclosporine ophthalmic emulsion) 0.05% |
PDF |
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% |
PDF |
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% and RESTASIS MULTIDOSE™(cyclosporine ophthalmic emulsion) 0.05% |
PDF |
RHOFADE™ (oxymetazoline hydrochloride) cream, 1% |
PDF |
SAPHRIS® (asenapine) sublingual tablets |
PDF |
SARAFEM (fluoxetine hydrochloride tablets) |
PDF |
Savella® (milnacipran HCl) Tablets |
PDF |
TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) |
PDF |
TAZORAC® (tazarotene) Cream 0.05% and 0.1% |
PDF |
TAZORAC® (tazarotene) Gel 0.05% and 0.1% |
PDF |
TEFLARO® (ceftaroline fosamil) for injection, for intravenous use |
PDF |
Thyrolar Tablets (Liotrix Tablets, USP) *
Currently unavailable due to shortage of the T3 component. For medical/product related questions, please call +1-800-678-1605. |
PDF |
TRELSTAR® (triptorelin pamoate for injectible suspension) |
PDF |
URSO 250® (ursodiol) tablets, for oral use,URSO Forte® (ursodiol) tablets, for oral use |
PDF |
VANIQA® (eflornithine hydrochloride) Cream, 13.9% |
PDF |
VIBERZI (eluxadoline) tablets, for oral use, CIV |
PDF |
VIIBRYD (vilazodone hydrochloride) tablets, for oral use |
PDF |
VIOKACE (pancrelipase) tablets, for oral use |
PDF |
VRAYLAR (cariprazine) capsules, for oral use
|
PDF |
ZENPEP® (pancrelipase) delayed release capsules |
PDF |
ZYMAXID® (gatifloxacin ophthalmic solution) 0.5% |
PDF |